Dr Kiran Piparva

Pharmacology 

Dr. Kiran G. Piparva

Assistant Professor

M.D. Pharmacology

    Email: kiranpiparva@yahoo.co.in

    2. Kanabar B, Malek S, Piparva K. Temporal Trends in Outbreaks of Chandipura Viral Infection in India: A Systematic Review. Cureus. 2024 Aug 29;16(8):e68097. doi: 10.7759/cureus.68097. PMID: 39347223; PMCID: PMC11437697.
    3. Kanabar B, Piparva KG, Pandya D, Kanabar RB. The Impact and Challenges of the Implementation of 5S Methodology in Healthcare Settings: A Systematic Review. Cureus. 2024 Jul 16;16(7):e64634. doi: 10.7759/cureus.64634. PMID: 39149689; PMCID: PMC11326763.
    4. Kanabar B, Piparva KG, Kanabar RB. Povidone-Iodine Induced Allergic Contact Dermatitis in a 10-Year-Old Girl: A Case Report. Cureus. 2024 Jul 22;16(7):e65121. doi: 10.7759/cureus.65121. PMID: 39171056; PMCID: PMC11338472.
    5. Piparva KG, Fichadiya N, Joshi T, Malek S. Monkeypox: From Emerging Trends to Therapeutic Concerns. Cureus. 2024 Apr 23;16(4):e58866. doi: 10.7759/cureus.58866. PMID: 38800170; PMCID: PMC11116278.
    6. Piparva KG, Dutta S, Singhal S, Shah R. A critical evaluation of contents, labeling, and cost of hand sanitizers marketed in India during COVID‑19 pandemic. J Family Med Prim Care 2024;13:2289-94.
    7. Savaliya S, Modi K, Singh A, Piparva K. Analysis of prescription pattern, treatment, and clinical outcome in chronic obstructive pulmonary disease patients at tertiary care teaching hospital. Pollo Medicine. 2024;[Online First]. Available from: https://doi.org/10.1177/09760016241258332.
    8. Dutta S, Shah R, Singhal S, Singh S, Piparva K, Katoch CDS. A systematic review and meta-analysis of tolerability, cardiac safety and efficacy of inclisiran for the therapy of hyperlipidemic patients. Expert Opin Drug Saf. 2024 Feb;23(2):187-198. doi: 10.1080/14740338.2023.2293201. Epub 2023 Dec 19. PMID: 38063346.
    9. Singhal S, Shah RB, Piparva KG, Dutta S. Are we providing complete drug information to its users? Status of information adequacy of package insert in India. J Family Med Prim Care. 2023 Jul;12(7):1399-1405. doi: 10.4103/jfmpc.jfmpc_1883_22. Epub 2023 Jul 14. PMID: 37649754; PMCID: PMC10465050.
    10. Kotecha K, Piparva KG, Kothari V, Modha J. Knowledge, Attitude and Perception of Pharmacovigilance Science in Ayurveda among Ayurved pharmacy undergraduates - A Cross-Sectional Study. J Ayurveda Integr Med Sci 2023;09:59-64.  http://dx.doi.org/10.21760/jaims.8.9.10
    11. Piparva K, Singh A, Joshi N. Compliance of Appointment, Antidiabetic Treatment, and Diet in Type 2 Diabetes Mellitus Patients at Private Diabetes Clinic. Dubai Diabetes Endocrinol J 2022;28 :112–118 DOI: 10.1159/000525373.
    12. Karelia BN, Piparva KG, Patel P. Prescription pattern study in type 2 diabetes mellitus in diabetic out patients at private clinic. European Journal of Molecular & Clinical Medicine, 2021, 8 (4) P: 79-87.
    13. Kiran PG, Anil SP, Karmur M. Prescription pattern and cost variation analysis in type 2 diabetes mellitus patients at private outpatient department. 2021;12: 11-14. 
    14. Thakkar D, Piparva KG, Lakkad SG. A pilot project: 99DOTS information communication technology-based approach for tuberculosis treatment in Rajkot district. Lung India 2019; 36:108-11. (INDEXED)
    15. Savaliya SM, Singh AP, Piparva KG. A donor hemovigilance study: evaluation of adverse reactions to blood donors at tertiary care teaching hospital. Int J Basic Clin Pharmacol 2019; 8:1538-41.
    16. Damor RR, Kubavat AR, Piparva KG. Drug reaction with eosinophilia and systemic symptom induced by carbamazepine: a case report. Int J Basic Clin Pharmacol 2019; 8:1115-8.
    17. Piparva KG, Jansari G, Singh AP. Evaluation of treatment outcome and adverse drug reaction of directly observed treatment (DOT) plus regimen in multidrug-resistant tuberculosis (MDR-TB) patients at district tuberculosis centre Rajkot. Perspect Clin Res. 2018 Oct-Dec; 9(4): 165–169.doi: 10.4103/picr.PICR_165_17.
    18. Piparva KG: Treatment outcome of tuberculosis patients on dots therapy for category 1 and 2 at district tuberculosis centre. Int J Pharm Sci Res 2017; 8(1): 207-12.doi: 10.13040/IJPSR.0975-8232.8(1).207-12.
    19. Lalwani US, Pillai A and Piparva KG: Drug utilization pattern among geriatric patients in a tertiary care teaching hospital. Int J Pharm Sci Res 2017; 8(3): 1249-54.doi: 10.13040/IJPSR.0975-8232.8(3).1249-54.
    20. Piparva KG, Singh AP. A Cross Sectional Pilot Study of Knowledge, Attitude and Practice of Pharmacovigilance among Pharmacists at Rajkot District. J Basic Clin Pharma 2017;8: S20-S23.
    21. Dela AI, Tank ND, Singh AP, Piparva KG. Adverse drug reactions and treatment outcome analysis of DOTS plus therapy of MDR-TB patients at district tuberculosis centre: A four-year retrospective study. Lung India 2017;34: 522-6.
    22. Parul AP, Bharti NK and Kiran GP: Dysmenorrhoea: prevalence, impact and knowledge aspect of treatment in females of reproductive age in tertiary care teaching hospital. Int J Pharm Sci Res 2016; 7(11): 4556-60.doi: 10.13040/IJPSR.0975-8232.7(11).4556-60.
    23. Karelia BN, Piparva KG. Knowledge, attitude and practice of pharmacovigilance among private healthcare professionals of Rajkot city. Int J Basic Clin Pharmacol 2014; 3:50-3. (INDEXED)
    24. Agravat VJ, Agarwal S, Piparva KG. Crimean - Congo haemorrhagic fever: an overview. Int J Res Med Sci 2014; 2:392-7.
    25. Patel BS, Kubavat A, Piparva K. Correlation of student's performance in theory and practical of final summative pharmacology examination in M.B.B.S curriculum: A critical insight. Natl J Physiol Pharm Pharmacol 2013; 3:171-175.1. 
    26. Piparva KG, Parmar DM, Singh AP, Gajera MV, Trivedi HR. Drug utilization study of      psychotropic drugs in outdoor patients in a teaching hospital. Indian J Psychol Med 2011;33: 54-8.
    27. Piparva KG, Buch JG, Chandrani KV. Analysis of adverse drug reactions of atypical antipsychotic drugs in psychiatry OPD. Indian J Psychol Med 2011;33: 153-7.
    28. Piparva KG, Buch JG. Deep vein thrombosis in a woman taking oral combined contraceptive pills. Journal of Pharmacology & Pharmacotherapeutics. 2011 Jul;2(3):185-186. DOI: 10.4103/0976-500x.83284.
    29. Piparva KG, Singh AP, Joshi N. Compliance of appointment, antidiabetic treatment and diet among type 2 diabetes mellitus at private diabetes clinic. Dubai Diabetes Endocrinol J. DOI: 10.1159/000525373.

          1.  

            Membership of professional/academic/research bodies:

                1. Indian Journal of Pharmacology (IJP)
                2. Indian Medical Association (IMA)
                3. National Medical Organization (NMO)
                4. Association of Physiologist and Pharmacologist of India (APPI)
                5. Society of Antimicrobial Stewardship Practices (SASPI)
                6. Indian Society of Rational Therapeutics (ISRPT)
                7. Indian Society of Clinical Research (ISCR)

          3.  

             

            Guest lecture/Awards:

          4. Presented a guest lecture on 'Pharmacovigilance for Ayurveda, Siddha, Unani, and Homeopathy Medicines' at the Institute of Teaching and Research in Ayurveda - Pharmacy, Jamnagar, on 16th February 2022.
          5. Presented a guest lecture on “History of Ethics in Human Research” at the national conference, ETHICON 2023 held virtually on 8th & 9th, January, 2024
          6. Presented a lecture on “Good Clinical Practice- History of Journey in Human Research” at the Workshop on “Good Clinical Practices” at P.D.U. Government Medical College, Rajkot. (2013)
          7. Guest speaker at refresher course of Pharmacy by Gujarat Pharmacy Council and on “Pharmacovigilance- ADR Reporting” at Atmiya University Rajkot.
          8. Presented lecture on “Rational Use of Medicine” at Gardi Pharmacy College, Rajkot.
          9. Presented lecture on “History of Good Clinical Practice” at Workshop on “Good Clinical Practices” conducted by Gokul Hospital Rajkot.
          10. Presented lecture on “Pharmacovigilance of Ayurveda, Siddha and Unani (A, S & U)” at Gujarat Ayurved University Jamnagar in 2021.
          11. Speaker at “Ethicon 2023” on “History of Ethics and GCP in medical research” at ETHICON 2023 on 7th & 8th January 2024
          12. Speaker at “National workshop on Pharmacovigilance in ASU & H Drugs” at Institute of Teaching and Research in Ayurveda, Jamnagar, Gujarat on 11th March 2024
          13. Received the First Prize for participating in the poster competition on 'End Obesity, End Hunger,' organized by the Department of Community and Family Medicine, All India Institute of Medical Sciences, Rajkot, on World Health Day, 6th April 2022."
          14. Presented a poster on “BE ANTIBIOTICS AWARE” -Can We Stop Antimicrobial Resistance (AMR)?: Prevent AMR- Save Antibiotics: Save Lives” (Piparva KG, Shah R, Dutta S, Singhal S, Kadeval A.) at “7th ASPIRE Pharmacology Insight and Rapid Review Course” organised by Sri Ramachandra Institute of Higher Education and Research, Chennai in 11,18,19,24, 25th February 2023.